SCRS Sites Directory

Search SCRS member sites. Discover current trials.

Cedar Health Research

Clinical Trials Powered By State of the Art Patient Matching Technology

Cedar Health Research

Direct Practice-to-Site EMR Integration: A multi-therapeutic site and patient network. Though its direct practice-to-site EMR Integration it forms a unique business model with unique capabilities that allow expansion of clinical trial access to diverse populations in and around our stand-alone dedicated sites across the Dallas-Fort Worth Metroplex and other cities in Texas.

Community Healthcare Partnerships: Formed partnerships with practice providers located in  different geographical areas across the Dallas - Fort Worth metroplex where patients of different age, racial backgrounds and socioeconomic statuses are found. 

A/I Powered Feasibility & Patient Matching: By using A/I technology to integrate into the partner practice's EMR system, we are then able to apply custom queries that review the structured and unstructured medical records of patients, at a granular level, inclusive of their disease and/or specific vaccine history (dosage and time intervals) that meet trial criteria.

Reduced Enrollment Timelines: The capability to match candidates to trials from our partner community practices. We then perform the trials ourselves making the clinical trial process highly efficient. We have a focus on recruiting diverse populations and have had success in enrolling underrepresented groups to our trials in past and current trials performed at our sites. At present we have access to 500+ physician practice EMR representing 1.8 million patients.

Centralized Recruitment Team: A patient-centric, multilingual, medically trained clinical team & staff, including Recruiters, Research Coordinators and Principal Investigators who are customer-service focused and are made available to subjects as emergency on call, available 24 hours a day, seven days a week.


Demographic Data

  • Start year clinical research2019
  • Phases of clinical studiesPhase I, Phase II, Phase III, Phase IV
  • Types of studiesBiologics, Drugs, Medical Devices, Nutraceuticals, Vaccines
  • PopulationsInfant 0-1yr, Child 2-10 yrs, Adolescent 11-17 yrs, Adult 18-64 yrs, Senior 65 yrs and over
  • Type of siteFreestanding
  • # of employees involved in research25
  • # of investigators16
  • Number of studies last year17
  • Days openMonday, Tuesday, Wednesday, Thursday, Friday, Saturday
  • Extended office hoursYes
  • Dry iceYes
  • Blinded pharmacistYes
  • Dedicated monitoring spaceYes
  • Internet access for the monitorYes
  • Onsite laboratoryYes
  • Central laboratoryYes
  • Infusion capabilityYes
  • Shipping optionsFedEx, UPS, DHL
  • Contact for regulatory documentsSaumya Sunny- Quality & Regulatory Manager
  • Regulatory phone number2142538170
  • # of days to turn around regulatory documents10 days
  • Type of IRB used by this siteCentral
  • Appropriate storage facilities for productYes
  • Able to appropriately store Schedule II drugsYes
  • # days to turn around budget and contract1 week